Parathyroid hormone-related protein is an oncofetal protein with distinct proliferative and anti-apoptotic roles that are affected by nucleocytoplasmic shuttling. The protein's nuclear export is sensitive to leptomycin B, consistent with a CRM1 dependent pathway. We determined that the 109-139 region of parathyroid hormone-related protein was involved in its nuclear export by demonstrating that a C-terminal truncation mutant, residues 1-108, exports at a reduced rate compared to the wild type 139 amino acid isoform. We searched for potential nuclear export sequences within that the 109-139 region, which is leucine-rich, contained a nuclear export sequence. Comparisons to established nuclear export sequences identified a putative consensus signal at residues 126-136. Deletion of this region resulted in nuclear export characteristics that closely matched those of the C-terminal truncation mutant. Confocal microscopic analyses of transfected 293, COS-1 and HeLa cells showed that steady state nuclear levels of the truncated and deletion mutants were significantly greater than levels of wild type parathyroid hormone-related protein and were unaffected by leptomycin B, unlike the wild type protein. In addition, both mutants demonstrated greatly reduced nuclear export with assays using nuclear preparations and intact cells. Based on these results, we conclude that the 126-136 amino acid sequence closely approximates the structure of a CRM1-dependent leucine rich nuclear export signal and is critical for nuclear export of parathyroid hormone-related protein.
Introduction
Transport of large macromolecules into and out of the nucleus is a regulated process that requires binding to specific transport proteins to traverse the nuclear pore complex (NPC). The ability of a protein to complex with import and export proteins is endowed by nuclear localization signals (NLS) or nuclear export signals (NES), respectively. NLS's are frequently monopartite or bipartite clusters of basic residues that mediate binding to a member of the karyopherin nuclear transport family, such as importin (1) . On the other hand, an NES is a loosely conserved motif typically consisting of specifically spaced sequences of leucines or other hydrophobic amino acids, typically separated by charged or polar spacer amino acids. A protein containing a leucine-rich NES can form a complex with nuclear export receptor CRM1
(chromosome region maintenance protein 1/exportin-1/XPO1) and the small GTPase protein Ran in its GTP bound form (2) . This complex is then translocated from the nucleus to the cytoplasm by facilitated diffusion through the NPC. RanGAP, a cytoplasmic protein, activates the intrinsic GTPase activity of Ran; hydrolysis of the terminal phosphate of GTP disrupts the NES-CRM1-Ran complex and releases the shuttled protein into the cytoplasm. CRM1 then cycles back to the nucleus for another round of NES export. Leptomycin B (LMB), a small fungicide derived from a strain of Streptomyces, inhibits CRM1-mediated transport by interfering with the association of CRM1 and the NES (3, 4) .
Parathyroid hormone-related protein (PTHrP) is best known for mediating hypercalcemia when secreted by solid tumors (5). However, the protein can act locally at the cells of many normal tissues and cancers not connected with hypercalcemia. The local effects include paracrine or autocrine actions on growth, apoptosis and smooth muscle relaxation, as well as on calcium transport (6) (7) (8) (9) (10) . Several portions of the molecule act at the cell surface, presumably 4 through receptor binding, but the only known receptor is the PTH/PTHrP receptor that is shared between PTHrP 1-34 and PTH 1-34. The protein can also escape the secretory pathway to remain inside the cell (11, 12) . Intracellular retention has functional significance; PTHrP exerts intracrine effects in the cell nucleus, predominantly affecting growth and apoptosis (13, 14) .
Nuclear localization of PTHrP represents a balance between nuclear import and export and appears to be regulated in some cell types (15). PTHrP possesses an NLS within residues 67-94 that is capable of binding to importin directly without an intervening role for importin (11, 16) . Inside the nucleus, PTHrP targets the nucleoli in most tissues, likely through the auspices of additional basic residues close to the NLS (13, 17) . The protein resides in the nuclei during the G1 phase of the cell cycle, but phosphorylation of threonine 85 by cdk2 during S phase reduces the rate of nuclear import and shifts PTHrP to the cytoplasm (15, 18). Cell cycle based redistribution of nuclear PTHrP could not occur if the protein did not shuttle back and forth from cytoplasm to nucleus.
PTHrP fused to green fluorescent protein (GFP) has been demonstrated to undergo nuclear export and the rate of export is sensitive to LMB, demonstrating that transport depends on CRM1 (12) . However, the precise location of the NES of PTHrP has not been identified.
Our goal in this study was to determine whether PTHrP is exported from the nucleus directly via a leucine-rich NES. Based on the primary structure, we considered the amino acid 109-139 sequence, which contains many leucine residues, as the most likely region of PTHrP to contain an NES. We performed sequence analyses comparing PTHrP 109-139 with known NES's from other proteins and selected a smaller domain to test as a putative NES. We then evaluated the importance of this region for nuclear export of GFP-containing PTHrP chimeras that contained the full sequence or various deletion mutations. 6 AGCAAGGGCGAGGAGCTG-3' and reverse 5'-ACCgtcgacCTTGTACAGCTCGTCCATGCC-3' were used to make the GFP 3 PCR product. After digesting both the pEGFP-C1 vector and the 5' Bgl II and 3' Xho I PCR product with Bgl II and Xho I, the fragments of interest were gel-purified from a 1% SeaPlaque low melting point agarose gel (Cambrex, Baltimore, MD), extracted using a QIAquick gel extraction kit (QIAGEN Inc., Valencia, CA), and ligated together in a 1:1 molar ratio to make the pEGFP 2 vector. To convert the pEGFP 2 vector to a pEGFP 3 vector, the same cloning procedure was followed using the second PCR insert containing the 5' Xho I and 3' Sal I sites and the pEGFP 2 vector with Xho I and Sal I as restriction enzymes.
The GFP 3 -PTHrP 1-108, 139, and 173 constructs were created by transferring the PTHrP insert from their respective single GFP expression vectors using Sal 1 and Xba 1 with the same reagents and cloning procedures as described above.
Mutagenesis
To generate the mutations within PTHrP 126-139, we used the Quick change XL kit (Stratagene, La Jolla, CA) as per the manufacturer's recommendations. Mutations were confirmed by DNA sequencing.
Cell Culture
HeLa, COS-1 and 293 cells, derived from human ovarian cancer, African green monkey kidney, and human embryonic kidney, respectively, were obtained from American Type Culture Collection (Manassas, VA). The cells were grown in monolayer using DMEM (Cellgro, Herndon, VA) supplemented with 5-10% fetal bovine serum (FBS) (Gemini Bio-Products, Woodland, CA) in a humidified incubator at 37 o C with 95% air and 5% CO 2 .
Transfections
For transfection studies, the cells were plated at 60-70% confluency and incubated overnight as described above. The 293 and HeLa cells were transfected using GenePORTER-2 (Gene Therapy Systems San Diego, CA) and the COS-1 cells were transfected using GenePORTER-1 according to the manufacturer's instructions. Typical transfection efficiencies were approximately 75, 55, and 90% for 293, HeLa, and COS-1 cells, respectively, as measured by the percentage of cells fluorescing in pEGFP-C1 transfected cell preparations.
Immunoblotting
COS-1 cells were trypsinized after transfection and pelleted by centrifugation at 200-x g for 5 min. The cell pellets were sonicated for 10 sec in RIPA buffer (PBS with 1% NP-40, 0.1% SDS, and 0.5% sodium deoxycholate) and total protein concentrations in the cell lysates were measured using a BCA protein assay (Pierce Chemical Co., Rockford, IL). The proteins (20 µg/lane) were separated using a 4-12% Bis-Tris SDS-PAGE gel in MOPS buffer (Invitrogen Corp., Carlsbad, CA) and then transferred to a nitrocellulose membrane. The membrane was blocked for non-specific binding by incubating in 10% nonfat dry milk (NFM) in TBS (10mM Tris-HCl, pH 8.0, 150 mM NaCl) for 30 min, washed three times in TBS, and incubated in the presence of 1 µg/ml anti-GFP monoclonal antibody (Molecular Probes, Eugene, OR) in 5% NFM overnight at 4 o C on a rotating shaker. In between multiple washes, the membrane was incubated in goat-anti-mouse IgG conjugated to horseradish peroxidase (Calbiochem, San Diego, CA), diluted in 5% NFM overnight at 4 o C on a shaker. The immunoreactive proteins were detected using a chemiluminescence reaction kit (Pierce Chemical) and exposed for 1-2 min on a Kodak MIN-R 2000 X-ray film (Eastman-Kodak Co., Rochester, NY). To 8 control for protein loading, the membranes were subsequently immunostained for -tubulin levels (Santa Cruz Biotechnology, Inc., Santa Cruz, CA).
PTHrP Immunoassays
Conditioned media and cell extracts from transfected cells were assayed for PTHrP expression by region-specific radioimmunoassays (20, 21 interest (AOI) as follows: First, the AOI was positioned over a nuclear, non-nucleolar region and the average intensity was recorded. Next, the AOI was repositioned to a representative region of the cytoplasm of the same cell and the average intensity was recorded. Correct placement of the cytoplasmic AOI relative to the nucleus was confirmed using the Hoechst 33342 image, to define the nuclear boundary. The data were exported into Microsoft Excel (Microsoft, Redmond, WA) and the distribution of the fluorescent PTHrP protein between the nucleus and cytoplasm was quantified by the ratio of the fluorescence of the two compartments, F n/c .
Confocal Microscopy
All time course experiments were performed with a Zeiss Axiovert 110M microscope equipped with an LSM 510 confocal laser scanning system using the LSM software v3.2sp2 (Carl Zeiss MicroImaging, Inc., Thornwood, NY). The in vitro export assay and FRAP studies utilized a Plan Neofluor 40x/1.3 oil objective, while FLIP employed the 63x/1.4 oil objective. Scan settings were the same for all experiments: GFP was excited with 5% of Ar/Kr laser output on the 488nm wavelength laser line coupled to a BP505-550 emission filter. PI was excited using 40% of the Ar/Kr laser output on the 568nm laser line coupled to a LP585 emission filter. Two 12-bit 1024x1024 images were obtained in line mode at a rate of 3.9 sec per image (7.8 sec total scan time) and averaged to reduce background noise. Generally, six one-micron Z-stacks were obtained for each scan to adjust for focal drift. At each time point, the analysis used the Z stack with the optimal plane of focus. The LSM software has a photobleaching technology that deserves further description.
The laser scans in a raster pattern and uses a shutter guided by a user defined bleaching AOI to control whether an individual point in the field is excited or not. The AOI is selected with the polygon drawing tool and can take an irregular shape (22) . Thus, the bleaching template can include the entire cytoplasm but exclude the nucleus, as shown in Fig. 8A using a FRAP experiment as an example. We typically use the phase contrast image to aid in drawing the AOI.
The area of the template was kept nearly constant from cell to cell and was set slightly larger than each of the cells studied. Thus the laser dwell time and the interval between images was relatively even among the analyses.
The purpose of the FLIP studies was to determine the importance of sequences within the PTHrP 109-139 region for nuclear export of PTHrP. We compared export rates for GFP-PTHrP 1-108 and GFP-PTHrP 1-139 because the two proteins are close in size, 39 vs. 42 kDa, respectively. The upper size limit at which passage through the NPC is restricted is only slightly larger. In contrast, GFP at 27 kDa is well below the size limit for passive diffusion through the NPC. In FLIP studies, it escapes the nucleus nearly as rapidly as cytoplasmic GFP can be photobleached (23) .
In vitro Nuclear Export Assay
This assay was adapted from protocols described by others (3, 19) . 
FRAP
Cells were transfected with GFP 3 -PTHrP chimeras and treated before the experiment with cycloheximide as described for FLIP. The PI track was disabled and the pinhole size for the GFP track was adjusted to 1.5 airy units. One image was acquired before photobleaching to outline an AOI including the entire cytoplasm as described above. The selected region was bleached for 80 iterations with a laser output of 100%. Bleaching the GFP 3 chimeras required a higher output than the 50% used for the single GFP constructs that were used for FLIP. Scans were then collected with the standard scan settings on a continuous cycle for the remained of the assay with no further bleaching.
Fluorescence in nuclear and cytoplasmic compartments were measured with ImagePro, exported to Excel and expressed as the nuclear to cytoplasmic ratio (F n/c ). The kinetics of export were analyzed by fitting data-points exponentially using SigmaPlot software (SPSS, Chicago, IL) to a three parameter model adapted from models used by others (25):
where top is the relative F n/c ratio immediately after photobleaching and span represents the extent of exported protein. Half-time of nuclear export, t 1/2 , was defined as ln(2)/k.
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RESULTS
GFP-PTHrP 1-108 exports from the nucleus at a slower rate than GFP-PTHrP 1-139
HeLa cells transiently transfected with GFP-PTHrP 1-139 or GFP-PTHrP 1-108 demonstrated cytoplasmic and nuclear GFP fluorescence, with signal localizing to nucleoli as well (Fig. 1A , left panels). Nucleolar fluorescence for the truncation mutant chimera was greater than for the wild type construct. Continual photobleaching with the FLIP protocol reduced cytoplasmic fluorescence to background after 100 sec (image not shown). After 600 sec, nuclear fluorescence had been lost compared to baseline for both constructs. The decrement was noticeably greater for GFP-PTHrP 1-139 compared to GFP-PTHrP 1-108 (Fig. 1A , right panels.
Bleaching maintained cytoplasmic fluorescence at background levels. Image analysis showed that nuclear fluorescence decreased linearly with time for both GFP-PTHrP chimeras, but GFP PTHrP 1-108 exported at a significantly (P < 0.01) slower rate than GFP PTHrP 1-139 (Fig. 1B) .
Sequence Alignments of Known NES's with PTHrP 109-139
We compared experimentally verified NES's to the PTHrP 109-139 sequence (26) (Fig.   2 ). Three leucine-rich sequences within the 109-139 region, PTHrP 112-121 (pNES1), PTHrP116-126 (pNES2) and PTHrP126-136 (pNES3), had at least partial homology with other known export signals (Fig. 2) . NES consensus sequences are typically ~10 amino acids in length with a semi-defined consensus of "LX 2-3 LX 2-3 LXL" (27) (28) (29) . The last three residues appear to be the most critical for function; typically they consist of a leucine or isoleucine separated by a single polar amino acid from a final leucine (30) . The earlier leucine positions in the consensus are not as critical and may be substituted occasionally by other amino acids. Based on these criteria, PTHrP 126-136 was the region most likely to be an NES. That sequence presented significant homology with known NES in human MAPKK/MEK1, human p53, human PKI and other proteins that undergo nucleocytoplasmic shuttling. In particular, it contained the requisite structure in its ultimate tripeptide, LEL 134-136 . The two upstream candidate sequences lacked the penultimate leucine residue. Jans and colleagues suggested in a review article that this region was a likely NES for PTHrP, although they provided no supporting data or references (15).
Because of our own sequence analyses and the supporting literature, we focused on PTHrP 126-136 as the potential NES in subsequent mutagenesis studies.
Constructs to test regulated nuclear export of PTHrP
We engineered new chimeric PTHrP forms to study the role of pNES3 in active export of PTHrP. The single GFP chimeric proteins are small enough in mass, less than 48 kDa, to diffuse through the NPC (31) without the assistance of CRM1. To prevent passive mechanisms in the export assays, we made the chimeras large using a triple GFP expression vector (GFP 3 ) (Fig. 3) analogous to one described by a previous investigator (32) . We confirmed the identity of the constructs by DNA sequencing and we demonstrated their functionality with transfection studies. (Fig. 4) . The GFP 3 vector protein was effectively restricted from the nucleus, as expected for its size. In contrast, the GFP 3 -PTHrP chimeric proteins, which include the PTHrP NLS, were distributed to cytoplasm, nucleus and also nucleoli (Fig. 5) .
The nuclear export studies utilized three chimeric PTHrP variants, GFP 3-wild type PTHrP 
Nuclear level of GFP 3 -PTHrP chimeras under steady state conditions
The distribution of GFP 3 -PTHrP chimeric proteins between cytoplasm and nucleus differed significantly among 293 cells transiently transfected with GFP 3 -PTHrP 1-139, GFP 3 -PTHrP 1-139 127-136, and GFP 3 -PTHrP 1-108 ( Figure 6 ). The steady state ratio of nuclear to cytoplasmic fluorescence (F n/c ) was over two-fold greater for the deletion and truncation mutants than for the wild type 1-139 chimera. The constructs also presented different sensitivities to LMB. Treatment with LMB increased the F n/c for the wild-type construct but had no effect on the two mutants.
In vitro assays of GFP 3 -PTHrP nuclear export
Nuclear export was measured with an in vitro assay utilizing permeabilized transfected COS-1 cells. The permeabilized cells were bathed in a buffer containing all the components necessary for nuclear export except RanGTP. Export began after adding RanGTP and resulted in a decrease in nuclear GFP fluorescence for the wild type GFP-PTHrP 1-139 chimera with levels approaching background after about 15 min (Fig. 7A ). In contrast, nuclear fluorescence for 
FRAP Assays of Nuclear Export of GFP 3 -PTHrP constructs in Intact Cells
Intact COS-1 cells expressing GFP 3 -PTHrP chimeras were incubated with cycloheximide to prevent synthesis of de novo GFP-containing protein and then underwent a period of photobleaching to diminish fluorescence substantially throughout the cytoplasm (Fig. 8) . Micrographs in Fig. 8A illustrate how the template was drawn for the bleaching AOI and the course for a typical FRAP assay. The template surrounds the cytoplasm except for a narrow path taken to outline and exclude the nucleus.
The middle panel demonstrates that the photobleaching reduced cytoplasmic fluorescence to background levels in most of the cell, but left nuclear fluorescence intact. The right-hand panel shows that cytoplasmic fluorescence began to recover at the end of the assay due to protein exported out of the nucleus. Nuclear fluorescence was perceptibly diminished. The three micrographs were exposed with same settings and processed to visualize the low levels of cytoplasmic fluorescence after recovery in the final image. The cellular fluorescence before bleaching was high and the pre-bleach image is saturated. 
20
A definitive statement cannot be made based on our data whether the other leucine-rich regions, pNES1 and pNES2, contribute to nuclear export. Since the GFP 3 -PTHrP 1-139 127-136 construct contained intact pNES1 and pNES2 sequences, the other putative NES's in the 109-139 region may not be as important as pNES3 in determining nuclear export of PTHrP. However, we did not test individual deletion mutations of pNES1 or pNES2 and cannot exclude the possibility that these regions might augment transport in the presence of pNES3. However, pNES1 and pNES2 groups did not support nuclear export of GFP 3 -PTHrP 1-139 127-136 in the in vitro assay. Also they were not enough to mediate LMB-sensitive changes in steady state levels of GFP 3 -PTHrP 1-139 127-136 (Fig 6.) . Clearly, pNES3 is necessary for CRM1 interaction and PTHrP export, but whether the sequence is sufficient to mediate export is unknown.
Our results are qualitatively similar in several respects to studies presented by Lam and colleagues. They also showed that LMB increases the nuclear level of a GFP-PTHrP fusion protein and decreases the rate of nuclear export of that protein (12, 33) . Protein expression was decreased for the GFP 3 -chimeric proteins compared to the expression of GFP 3 protein. We have not established the reason for the difference. One possible explanation is that the presence of nuclear GFP 3 -PTHrP chimeric protein might decrease protein synthesis through an effect on ribosomal function. PTHrP is known to localize to bind to ribosomal RNA (13, 34) . We also found 21 that nucleolar accumulation of GFP-PTHrP chimeras appeared to exceed that of the triple GFP fusion proteins. We have no explanation at this time.
Additional work will be necessary to determine whether CRM1-mediated transport augments nuclear clearance of PTHrP above levels due to passive movement and whether the presence of absence of the PTHrP NES makes a difference in cell function or growth. Nuclear levels of PTHrP vary with cell cycle in UMR106 cells and the protein exerts effects that are specific for particular phases of the cell cycle (11, 35) . One might expect that exiting the nucleus at the right time would be important in regulating cell cycle-specific levels of the protein, but whether NES facilitates nuclear escape at specific phases is unknown.
Summary
PTHrP has been shown to export from the nucleus via the CRM1 pathway (12), but details about the signal sequence had not been established. CRM1 typically recognizes a nuclear export signal, a loosely defined consensus sequence that is rich in leucine moieties. The 126-136 region within PTHrP matched this NES consensus pattern, notably in its last three amino acids consisting of two leucines separated by a polar residue. A mutant was created in which the putative NES, pNES3, was disrupted by deleting 9 of the 10 residues. Four independent methods were used to assess the impact of this mutation on nuclear export of chimeric GFP 3 -PTHrP proteins. The GFP series provided a fluorescent tag and restricted passive nuclear shuttling.
Transport of the pNES3 mutant was significantly altered compared to the wild type PTHrP 1-139 chimera, suggesting that it was not exported by CRM1. These results indicate that PTHrP exports in the CRM1 nuclear export pathway via a leucine-rich NES and that the 126-136 region is a critical component of the NES. The importance of this sequence for nuclear egress of wild 22 type PTHrP 1-139, which can move in and out of the nucleus passively, and the physiologic significance of NES-mediated export of PTHrP require further study. 
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